kaziatherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Kazia Therapeutics |
| Description | We aspire to help patients and clinicians confront the most challenging cancers in modern Kazia is an Australian oncology company developing innovative, high-impact drugs for cancer. Our lead program is paxalisib, which is being developed to treat glioblastoma, the most common and most aggressive form of primary brain cancer in |
| Keywords | Kazia Therapeutics, ASX: KZA |
Server Information
| WebSite | |
| Host IP | 54.79.107.72 |
| Location | Australia |
Related Websites
| Site | Rank |
More to Explore
kaziatherapeutics.com Valuation
|
US$9,689,205
Last updated: 2023-04-29 02:10:29
kaziatherapeutics.com has Semrush global rank of 1,092,381. kaziatherapeutics.com has an estimated worth of US$ 9,689,205, based on its estimated Ads revenue. kaziatherapeutics.com receives approximately 1,117,986 unique visitors each day. Its web server is located in Australia, with IP address 54.79.107.72. According to SiteAdvisor, kaziatherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$9,689,205 |
| Daily Ads Revenue | US$8,944 |
| Monthly Ads Revenue | US$268,317 |
| Yearly Ads Revenue | US$3,219,798 |
| Daily Unique Visitors | 74,533 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| kaziatherapeutics.com. | A | 1800 | IP: 54.79.107.72 |
| kaziatherapeutics.com. | NS | 86400 | NS Record: ns-1195.awsdns-21.org. |
| kaziatherapeutics.com. | NS | 86400 | NS Record: ns-1850.awsdns-39.co.uk. |
| kaziatherapeutics.com. | NS | 86400 | NS Record: ns-426.awsdns-53.com. |
| kaziatherapeutics.com. | NS | 86400 | NS Record: ns-782.awsdns-33.net. |
| kaziatherapeutics.com. | MX | 3600 | MX Record: 20 filter2.kaziat-1.mailguard.com.au. |
| kaziatherapeutics.com. | MX | 3600 | MX Record: 30 filter3.kaziat-1.mailguard.com.au. |
| kaziatherapeutics.com. | MX | 3600 | MX Record: 10 filter1.kaziat-1.mailguard.com.au. |
| kaziatherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com include:customer.mailguard.com.au -all |
| kaziatherapeutics.com. | TXT | 3600 | TXT Record: google-site-verification=lZKoRNwwe4UfjoeqK6gcD7jNCkz_WQEUEYA2nLLfcKA |
HtmlToTextCheckTime:2023-04-29 02:10:29
| Home About Us About Us Board of Directors Scientific Advisory Board Management Team Careers For Researchers Paxalisib EVT801 Collaborating with Kazia Publications and Presentations For Partners Our Current Partners What We Are Looking For For Patients Accessing Kazia Drug Candidates in Clinical Trials Accessing Kazia Drug Candidates for Compassionate Use Resources for Patients For Investors ASX Announcements SEC Filings Corporate Presentations Annual Reports Financial Reports AGM Investor Newsletters Corporate Governance Shareholder Services Media Centre Overview Latest News Video Coverage Contact Contact Us Subscribe to email alerts --> Did you know that May is Brain Cancer Awareness Month? Kazia recently launched a Share Purchase Plan, offering an opportunity for existing Eligible Shareholders to subscribe for up to $30,000 worth of new, fully paid, ordinary shares in Kazia (SPP Shares), without incurring brokerage or other transaction costs. For information about Kazia’s Share |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 150 Content-Type: text/html; charset=utf-8 Location: http://www.kaziatherapeutics.com/ Strict-Transport-Security: max-age=31536000 Date: Thu, 21 Oct 2021 23:36:50 GMT HTTP/1.1 302 Found Cache-Control: private Cache-control: no-cache="set-cookie" Content-Length: 131 Content-Type: text/html; charset=utf-8 Date: Thu, 21 Oct 2021 23:36:50 GMT Location: /site/content/ Set-Cookie: AWSELB=6513754B1C5CC94C36D4FA97FE6911DC2DDBF7E46578628D015A9121F2184A1C3FF9BF0642C27E7A01616814D2D5248271BDE8AF0BEC647D418D1169CD37248CA537D3FA62;PATH=/;MAX-AGE=600 Strict-Transport-Security: max-age=31536000 Connection: keep-alive HTTP/1.1 302 Found Cache-control: no-cache="set-cookie" Content-Length: 164 Content-Type: text/html; charset=utf-8 Date: Thu, 21 Oct 2021 23:36:50 GMT Location: https://www.kaziatherapeutics.com/site/content/ Set-Cookie: AWSELB=6513754B1C5CC94C36D4FA97FE6911DC2DDBF7E46578628D015A9121F2184A1C3FF9BF0642C27E7A01616814D2D5248271BDE8AF0BEC647D418D1169CD37248CA537D3FA62;PATH=/;MAX-AGE=600 Strict-Transport-Security: max-age=31536000 Connection: keep-alive HTTP/2 200 cache-control: private content-length: 48000 content-type: text/html; charset=utf-8 set-cookie: ASP.NET_SessionId=xjyfn2docl0q4jsaktwhhg2d; path=/; secure; HttpOnly; SameSite=Lax strict-transport-security: max-age=31536000 date: Thu, 21 Oct 2021 23:36:51 GMT |
kaziatherapeutics.com Whois Information
Domain Name: KAZIATHERAPEUTICS.COM Registry Domain ID: 2155760363_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tppwholesale.com.au Registrar URL: http://www.melbourneit.com.au Updated Date: 2021-04-16T13:43:33Z Creation Date: 2017-08-22T04:47:04Z Registry Expiry Date: 2022-08-22T04:47:04Z Registrar: Netregistry Wholesale Pty Ltd Registrar IANA ID: 900 Registrar Abuse Contact Email: abuse@tppwholesale.com.au Registrar Abuse Contact Phone: +61342060102 Domain Status: ok https://icann.org/epp#ok Name Server: NS-1195.AWSDNS-21.ORG Name Server: NS-1850.AWSDNS-39.CO.UK Name Server: NS-426.AWSDNS-53.COM Name Server: NS-782.AWSDNS-33.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T18:24:09Z <<< |